The DOI matches its Crossref record; 310 of the 310 references it cites were found in a registry or an index.
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 2×
“…Tg2576 mice that do not exhibit significant b-amyloid plaque load, are caused by the extracellular accumulation of a 56-kDa soluble b-amyloid assembly (Ab 56), as Ab 56 purified from the brains of impaired Tg2576 mice disrupted memory when admin- istered to young rats (Lesn e et al., 2006).”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 2×
“in Alzheimer’s disease (Kosik et al., 1986; Lee et al., 1991).”
BackgroundHuman Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways
Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., & Teplow, D. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222681699 · Cited by 1,287
Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Fischer, W., Wictorin, K., Björklund, A., Williams, L. R., Varon, S., & Gage, F. H. (1987) · Nature · doi:10.1038/329065a0 · Cited by 1,024
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898
Neurobiology of butyrylcholinesterase
Darvesh, S., Hopkins, D. A., & Geula, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1035 · Cited by 891
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 828
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Self-citationBrain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
The Cholinergic Synapse and the Site of Memory
Deutsch, J. A. (1972) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-3060-8_11 · Cited by 739
Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 734
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
Winblad, B., Engedal, K., Soininen, H., Verhey, F., Waldemar, G., Wimo, A., Wetterholm, A.-L., Zhang, R., Haglund, A., Subbiah, P., et al. (2001) · Neurology · doi:10.1212/wnl.57.3.489 · Cited by 727
Neurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 718
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90255-6 · Cited by 697
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Pathology of Parkinson’s disease: Changes other than the nigrostriatal pathway
Jellinger, K. A. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159935 · Cited by 684
Kirkitadze, M. D., Condron, M. M., & Teplow, D. B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4970 · Cited by 682
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
Cognitive functions of cortical acetylcholine: toward a unifying hypothesis
Sarter, M., & Bruno, J. P. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00009-4 · Cited by 663
The Cholinergic Synapse and the Site of Memory
Deutsch, J. A. (1971) · Science · doi:10.1126/science.174.4011.788 · Cited by 661
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654
Mesulam, M.-M., Guillozet, A., Shaw, P., Levey, A., Duysen, E. G., & Lockridge, O. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00613-3 · Cited by 650
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Memory and cognitive function in man: Does the cholinergic system have a specific role?
DRACHMAN, D. A. (1977) · Neurology · doi:10.1212/wnl.27.8.783 · Cited by 614
Conn, P. M. (1992) · Methods in Neurosciences · doi:10.1016/b978-0-12-185269-6.50005-9 · Cited by 606
Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence
Fibiger, H. C. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90117-d · Cited by 599
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P., & Davis, K. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020749.x · Cited by 580
β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies
Bartolini, M., Bertucci, C., Cavrini, V., & Andrisano, V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01514-9 · Cited by 568
Cholinesterase inhibitors: new roles and therapeutic alternatives
GIACOBINI, E. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.017 · Cited by 555
CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE
PERRY, E. K., PERRY, R. H., BLESSED, G., & TOMLINSON, B. E. (1978) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1978.tb00545.x · Cited by 555
Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1745 · Cited by 551
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Amyloid-β oligomers: their production, toxicity and therapeutic inhibition
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Rowan, M. J., & Selkoe, D. J. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300552 · Cited by 507
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients
Mohs, R. C., Doody, R. S., Morris, J. C., Ieni, J. R., Rogers, S. L., Perdomo, C. A., Pratt, R. D., & for the “312” Study Group (2001) · Neurology · doi:10.1212/wnl.57.3.481 · Cited by 503
Hefti, F., Hartikka, J., Eckenstein, F., Gnahn, H., Heumann, R., & Schwab, M. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90163-0 · Cited by 491
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Eriksdotter Jönhagen, M., Nordberg, A., Amberla, K., Bäckman, L., Ebendal, T., Meyerson, B., Olson, L., Seiger, Å., Shigeta, M., Theodorsson, E., et al. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017069 · Cited by 472
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462
Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease
Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08501.x · Cited by 450
Cholinergic Basal Forebrain Neurons Burst with Theta during Waking and Paradoxical Sleep
Lee, M. G., Hassani, O. K., Alonso, A., & Jones, B. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0178-05.2005 · Cited by 439
Mutations causing neurodegenerative tauopathies
Goedert, M., & Jakes, R. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.007 · Cited by 438
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 434
Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor
Wiley, R. G., Oeltmann, T. N., & Lappi, D. A. (1991) · Brain Research · doi:10.1016/0006-8993(91)91199-b · Cited by 417
Arendt, T., Bigl, V., Tennstedt, A., & Arendt, A. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90160-5 · Cited by 410
Self-citationActivation of protein kinase C inhibits cellular production of the amyloid beta-protein.
Hung, A. Y., Haass, C., Nitsch, R. M., Qiu, W. Q., Citron, M., Wurtman, R. J., Growdon, J. H., & Selkoe, D. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49409-x · Cited by 405
Heckers, S., Ohtake, T., Wiley, R., Lappi, D., Geula, C., & Mesulam, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-03-01271.1994 · Cited by 401
Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 371
Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
Kar, S., Slowikowski, S. P. M., Westaway, D., & Mount, H. T. J. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0442 · Cited by 364
Li, B., Stribley, J. A., Ticu, A., Xie, W., Schopfer, L. M., Hammond, P., Brimijoin, S., Hinrichs, S. H., & Lockridge, O. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.751320.x · Cited by 354
Cholinesterases: Roles in the Brain During Health and Disease
Ballard, C., Greig, N., Guillozet-Bongaarts, A., Enz, A., & Darvesh, S. (2005) · Current Alzheimer Research · doi:10.2174/1567205054367838 · Cited by 350
Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications
Nordberg, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01125-2 · Cited by 339
(1990) · doi:10.1093/oso/9780198542667.001.0001 · Cited by 335
β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
Liu, Q.-S., Kawai, H., & Berg, D. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081553598 · Cited by 331
Alvarez, A., Alarcón, R., Opazo, C., Campos, E. O., Muñoz, F. J., Calderón, F. H., Dajas, F., Gentry, M. K., Doctor, B. P., De Mello, F. G., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03213.1998 · Cited by 317
Arendt, T., Brückner, M. K., Lange, M., & Bigl, V. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90189-x · Cited by 314
Self-citationLaw, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 314
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain
Mesulam, M., Guillozet, A., Shaw, P., & Quinn, B. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0462 · Cited by 314
Butyrylcholinesterase in the life cycle of amyloid plaques
Guillozet, A. L., Mesulam, M. ‐., Smiley, J. F., & Mash, D. C. (1997) · Annals of Neurology · doi:10.1002/ana.410420613 · Cited by 310
Alvarez, A., Opazo, C., Alarcón, R., Garrido, J., & Inestrosa, N. C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1245 · Cited by 306
Toth, K., Borhegyi, Z., & Freund, T. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03712.1993 · Cited by 302
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295
β-Amyloid1–42Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice
Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 290
Structural and kinetic features of amyloid β-protein fibrillogenesis: Review
Teplow, D. B. (1998) · Amyloid · doi:10.3109/13506129808995290 · Cited by 283
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Advanced glycation endproducts in ageing and Alzheimer's disease
Münch, G., Thome, J., Foley, P., Schinzel, R., & Riederer, P. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00016-1 · Cited by 275
Alzheimer disease: progress or profit?
Mount, C., & Downton, C. (2006) · Nature Medicine · doi:10.1038/nm0706-780 · Cited by 262
Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition
Ballard, C. G. (2002) · European Neurology · doi:10.1159/000047952 · Cited by 260
NGF improves spatial memory in aged rodents as a function of age
Fischer, W., Bjorklund, A., Chen, K., & Gage, F. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-07-01889.1991 · Cited by 259
Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia
Mesulam, ‐., & Geula, C. (1994) · Annals of Neurology · doi:10.1002/ana.410360506 · Cited by 258
Ginsberg, S. D., Che, S., Wuu, J., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03764.x · Cited by 255
Xie, W., Stribley, J. A., Chatonnet, A., Wilder, P. J., Rizzino, A., McComb, R. D., Taylor, P., Hinrichs, S. H., & Lockridge, O. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39312-7 · Cited by 255
Nitsch, R. M., Farber, S. A., Growdon, J. H., & Wurtman, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5191 · Cited by 244
β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
Dineley, K. T., Bell, K. A., Bui, D., & Sweatt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200066200 · Cited by 240
Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimerʼs disease
Narisawa-Saito, M., Wakabayashi, K., Tsuji, S., Takahashi, H., & Nawa, H. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00024 · Cited by 226
Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats
Biesold, D., Inanami, O., Sato, A., & Sato, Y. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90370-4 · Cited by 223
Counts, S. E., & Mufson, E. J. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.263 · Cited by 222
Nicotine Inhibits Amyloid Formation by the β-Peptide
Salomon, A. R., Marcinowski, K. J., Friedland, R. P., & Zagorski, M. G. (1996) · Biochemistry · doi:10.1021/bi9617264 · Cited by 220
Wright, C. I., Geula, C., & Mesulam, M. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410340312 · Cited by 219
Cholinergic-rich brain transplants reverse alcohol-induced memory deficits
Arendt, T., Allen, Y., Sinden, J., Schugens, M. M., Marchbanks, R. M., Lantos, P. L., & Gray, J. A. (1988) · Nature · doi:10.1038/332448a0 · Cited by 214
Self-citationOddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211
Cholinergic modulation of the cortical neuronal network
Lucas-Meunier, E., Fossier, P., Baux, G., & Amar, M. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0999-2 · Cited by 210
Nordberg, A., Hellström‐Lindahl, E., Lee, M., Johnson, M., Mousavi, M., Hall, R., Perry, E., Bednar, I., & Court, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00874.x · Cited by 209
Li, Y., Liu, L., Kang, J., Sheng, J. G., Barger, S. W., Mrak, R. E., & Griffin, W. S. T. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00149.2000 · Cited by 209
Kelly, J. F., Furukawa, K., Barger, S. W., Rengen, M. R., Mark, R. J., Blanc, E. M., Roth, G. S., & Mattson, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6753 · Cited by 209
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex
Rees, T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00230-0 · Cited by 207
Bartels, C. F., Jensen, F. S., Lockridge, O., van der Spek, A. F., Rubinstein, H. M., LUBRANO, T., & Du, B. N. L. (1992) · PubMed · Cited by 203
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 198
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Cognitive sequelae of head injury: involvement of basal forebrain and associated structures
Salmond, C. H. (2004) · Brain · doi:10.1093/brain/awh352 · Cited by 196
Cholinesterases and the Pathology of Alzheimer Disease
Geula, C., & Mesulam, M. M. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199501002-00005 · Cited by 193
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
Molchan, S. E., Martinez, R. A., Hill, J. L., Weingartner, H. J., Thompson, K., Vitiello, B., & Sunderland, T. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90017-g · Cited by 187
Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh
Isacson, O. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02037-4 · Cited by 187
Delaère, P., Duyckaerts, C., Masters, C., Beyreuther, K., Piette, F., & Hauw, J.-J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90391-l · Cited by 186
Luth, H.-J. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh123 · Cited by 186
α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation
Wang, H.-Y., Li, W., Benedetti, N. J., & Lee, D. H. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212532200 · Cited by 185
Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease
Counts, S. E., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., & Mufson, E. J. (2004) · Annals of Neurology · doi:10.1002/ana.20233 · Cited by 183
Berne, C., Gunnarsson, R., Hellerström, C., & Wilander, E. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92474-x · Cited by 175
Münch, G., Mayer, S., Michaelis, J., Hipkiss, A. R., Riederer, P., Müller, R., Neumann, A., Schinzel, R., & Cunningham, A. M. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(96)00062-2 · Cited by 174
Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence
Platt, B., Fiddler, G., Riedel, G., & Henderson, Z. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00511-1 · Cited by 174
Colocalization of cholinesterases with ? amyloid protein in aged and Alzheimer's brains
Mor�n, M. A., Mufson, E. J., & G�mez-Ramos, P. (1993) · Acta Neuropathologica · doi:10.1007/bf00334445 · Cited by 172
Donepezil Therapy in Clinical Practice: A Randomized Crossover Study
Greenberg, S. M., Tennis, M. K., Brown, L. B., Gomez-Isla, T., Hayden, D. L., Schoenfeld, D. A., Walsh, K. L., Corwin, C., Daffner, K. R., Friedman, P., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.94 · Cited by 169
Katoh-Semba, R., Semba, R., Takeuchi, I. K., & Kato, K. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00040-6 · Cited by 168
Beach, T. G., Kuo, Y., Spiegel, K., Emmerling, M. R., Sue, L. I., Kokjohn, K., & Roher, A. E. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.308 · Cited by 168
Yaar, M., Zhai, S., Fine, R. E., Eisenhauer, P. B., Arble, B. L., Stewart, K. B., & Gilchrest, B. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110929200 · Cited by 167
Schliebs, R. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6962-9 · Cited by 164
Self-citationDistribution of butyrylcholinesterase in the human amygdala and hippocampal formation
Darvesh, S., Grantham, D. L., & Hopkins, D. A. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980413)393:3<374::aid-cne8>3.0.co;2-z · Cited by 164
Neuroreceptor changes in Alzheimer disease.
Nordberg, A. K. (1992) · PubMed · Cited by 162
Nontoxic Amyloid β Peptide1-42 Suppresses Acetylcholine Synthesis
Hoshi, M. M., Takashima, A., Murayama, M., Yasutake, K., Yoshida, N., Ishiguro, K., Hoshino, T., & Imahori, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2038 · Cited by 161
Sarter, M. F., & Bruno, J. P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.011 · Cited by 159
Regulated secretion of beta-amyloid precursor protein in rat brain
Farber, S., Nitsch, R., Schulz, J., & Wurtman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07442.1995 · Cited by 158
The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex
Détári, L., Rasmusson, D. D., & Semba, K. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00084-7 · Cited by 157
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex
Mori, F., Lai, C.-C., Fusi, F., & Giacobini, E. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00012 · Cited by 157
Perini, G., Bianca, V. D., Politi, V., Valle, G. D., Prà, I. D., Rossi, F., & Armato, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011797 · Cited by 156
Brain‐derived neurotrophic factor and neurotrophin‐3 levels in Alzheimer's disease brains
Durany, N., Michel, T. M., Kurt, J., Cruz-Sánchez, F., Cervós‐Navarro, J., & Riederer, P. F. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00046-0 · Cited by 155
Acetylcholinesterase and Its Inhibition in Alzheimer Disease
Lane, R. M., Kivipelto, M., & Greig, N. H. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200405000-00011 · Cited by 153
Mechanisms Behind the Neuroprotective Actions of Cholinesterase Inhibitors in Alzheimer Disease
Nordberg, A. K. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213804.59187.2d · Cited by 151
Brain cholinergic vulnerability: Relevance to behavior and disease
McKinney, M., & Jacksonville, M. C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.019 · Cited by 148
Acetylcholinesterase-Aβ Complexes Are More Toxic than Aβ Fibrils in Rat Hippocampus
Reyes, A. E., Chacón, M. A., Dinamarca, M. C., Cerpa, W. F., Morgan, C., & Inestrosa, N. C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63774-1 · Cited by 148
Dunnett, S. B., & Fibiger, H. C. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62425-5 · Cited by 146
?-amyloid binds to p75NTRand activates NF?B in human neuroblastoma cells
Kuner, P., Schubenel, R., & Hertel, C. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981215)54:6<798::aid-jnr7>3.0.co;2-t · Cited by 145
Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus
Darvesh, S., & Hopkins, D. A. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10751 · Cited by 143
Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease
Geula, C., & Mesulam, M. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90419-8 · Cited by 140
Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease
Fuentealba, R. A., Farías, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 140
Bryson, H. M., & Benfield, P. (1997) · Drugs & Aging · doi:10.2165/00002512-199710030-00007 · Cited by 136
Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice
Hellström‐Lindahl, E., COURT, J. A., Keverne, J., Svedberg, M. M., Lee, M., Marutle, A., Thomas, A. J., Perry, E. K., Bednar, I., & Nordberg, A. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03377.x · Cited by 135
Pedersen, W. A., Kloczewiak, M. A., & Blusztajn, J. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8068 · Cited by 134
Sberna, G., Sáez‐Valero, J., Beyreuther, K. T., Masters, C. L., & Small, D. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031177.x · Cited by 132
The role of nicotinic acetylcholine receptors in Alzheimer’s disease
Oddo, S., & LaFerla, F. M. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.080 · Cited by 132
Pharmacodynamic-Tolerability Relationships of Cholinesterase Inhibitors for Alzheimer??s Disease
Imbimbo, B. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00004 · Cited by 130
Alzheimer’s disease and NGF signaling
Salehi, A., Delcroix, J., & Swaab, D. (2004) · Journal of neural transmission · doi:10.1007/s00702-003-0091-x · Cited by 128
Haring, R., Fisher, A., Marciano, D., Pittel, Z., Kloog, Y., Zuckerman, A., Eshhar, N., & Heldman, E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052094.x · Cited by 122
Mechanisms of ß-Amyloid Neurotoxicity: Perspectives of Pharmacotherapy
Harkany, T., Ábrahám, I. M., Kónya, C., Nyakas, C. J., Zarándi, M., Penke, B., & Luiten, P. G. M. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.4.329 · Cited by 122
Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.
Rabizadeh, S., Bitler, C. M., Butcher, L. L., & Bredesen, D. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10703 · Cited by 121
Apelt, J., Kumar, A., & Schliebs, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03262-6 · Cited by 121
Self-citationHöck, C., Maddalena, A. S., Raschig, A., Müller-Spahn, F., Eschweiler, G. W., Huger, K., Hewer, I., Hampel, H. J., Müller-Thornsen, T., Oertel, W. H., et al. (2003) · Amyloid · doi:10.3109/13506120308995249 · Cited by 119
Contribution of acetylcholine to visual cortex plasticity
Gu, Q. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00073-x · Cited by 118
Lin, L., Georgievska, B., Mattsson, A., & Ole Isacson, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12108 · Cited by 118
Adverse effects associated with the use of donepezil in general practice in England
Dunn, N. R., Pearce, G. L., & Shakir, S. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400410 · Cited by 117
Goekoop, R., Scheltens, P., Barkhof, F., & Rombouts, S. A. R. B. (2005) · Brain · doi:10.1093/brain/awh671 · Cited by 117
Fagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., & Holtzman, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6818 · Cited by 116
Cooper, J. D., Lindholm, D., & Sofroniew, M. V. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90462-6 · Cited by 116
Nicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro
Ono, K., Hasegawa, K., Yamada, M., & Naiki, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01417-8 · Cited by 116
Bernstein, H., Ansorge, S., Riederer, P. F., Reiser, M., Frölich, L., & Bogerts, B. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00135-4 · Cited by 115
Klein, A., Kowall, N. W., & Ferrante, R. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07845.x · Cited by 115
Ginsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111
Aging, Amyloid, and Alzheimer's Disease: A Perspective in Honor of Carl Cotman
Selkoe, D. J. (2003) · Neurochemical Research · doi:10.1023/a:1026065122854 · Cited by 110
Grassi, F., Palma, E., Tonini, R., Amici, M., Ballivet, M., & Eusebi, F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.035436 · Cited by 106
Grön, G., Brandenburg, I., Wunderlich, A. P., & Riepe, M. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.005 · Cited by 106
Reyes, A. E., Perez, D. R., Alvarez, A. R., Garrido, J., Gentry, M. K., Doctor, B. P., & Inestrosa, N. C. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6357 · Cited by 106
Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
Mielke, R., & Heiss, W. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_21 · Cited by 105
Capsoni, S., Giannotta, S., & Cattaneo, A. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1163 · Cited by 103
Berger-Sweeney, J. E. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00070-8 · Cited by 102
Kosik, K. S., Joachim, C., & Selkoe, D. J. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00022 · Cited by 100
The pharmacology of donepezil: a new treatment for Alzheimer’s disease
Wilkinson, D. G. (1999) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.1.121 · Cited by 97
DECREASED RATIO OF CSF ACETYLCHOLINESTERASE TO BUTYRYLCHOLINESTERASE ACTIVITY IN ALZHEIMER'S DISEASE
Arendt, T., Bigl, V., Walther, F., & Sonntag, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90116-8 · Cited by 96
Self-citationAlzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Yan, Z., & Feng, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331992 · Cited by 96
Jaffar, S., Counts, S., Ma, S. Y., Dadko, E., Gordon, M. N., Morgan, D., & Mufson, E. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7710 · Cited by 93
Zhang, Y., Hong, Y., Bounhar, Y., Blacker, M., Roucou, X., Tounekti, O., Vereker, E., Bowers, W. J., Federoff, H. J., Goodyer, C. G., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07385.2003 · Cited by 93
Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 92
Advances in the pharmacotherapy of Alzheimer's disease.
Gauthier, S. G. (2002) · Europe PMC (PubMed Central) · Cited by 92
Cited by
Alzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Self-citationConnections between sleep and cognition in older adults
Yaffe, K., Falvey, C. M., & Hoang, T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70172-3 · Cited by 796
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Zhao, C., Rakesh, K. P., Ravidar, L., Fang, W.-Y., & Qin, H.-L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.017 · Cited by 651
Metadata
- Authors
- Schliebs, R., & Arendt, T.
- Venue
- Journal of Neural Transmission
- Published
- 2006-10-13
- Volume
- 113
- Issue
- 11
- Pages
- 1625-1644
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2064111465
- Cited by
- 530
- References
- 310
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.